Abstract
COMPARATIVE STUDY BETWEEN DEXMEDETOMIDINE AND PROPOFOL FOR PAIN, AGITATION AND DELIRIUM IN INTENSIVE CARE

Sulakshana Sulakshana* and Rajesh Verma

ABSTRACT

Background: Severity of acute medical illness, invasive diagnostic and therapeutic interventions and environmental influences makes the patient prone to pain, agitation and delirium in intensive care units. Several drugs are used for sedation, but it was not clear that whether a single drug is able to address all the three components of pain, agitation and delirium effectively. This study compares dexmedetomidine with propofol in the management of critically- ill patients observing their effect on sedation, pain and delirium scores and other cardio-respiratory parameters. Material & Methods: After clearance from institute ethical committee and written informed consent, patients were randomly divided to two groups of thirty each. Group D received dexmedetomidine intravenous infusion in initial dose of 0.5 mcg/kg/hr over 20 minutes followed by 0.1 mcg/kg/hr, while Group P received propofol (0.5 mg/kg/hr). Infusion rate was titrated to achieve target sedation level. RASS(Richmond agitation sedation scale), CAM-ICU(Confusion assessment method- ICU),and CPOT(Critical care pain observation tool) scores were observed for a duration of 24 hours at baseline, 20 minutes after starting the study drug and subsequently at every four hours duration. Results: Mean RASS in Group D was significantly lower (-0.23 ± 0.50) than group P (0.57 ± 1.17)]. Mean CPOT was also significantly lower (1.30 ± 0.60) in the group D than group P (2.90 ± 1.32). Delirium was also lower (1/30) in the group D than group P (4/30) but this difference was not statistically significant. Conclusion: Both propofol and dexmedetomidine can be used as sedative agent in ICU but dexmedetomidine provides better analgesia and lesser delirium episodes than propofol and thus can be used as sole agent to effectively acts on all the three components pain, agitation and delirium simultaneously.

Keywords: Agitation, delirium, dexmedetomidine, pain, propofol.


[Full Text Article]

Login





Forgot Password  |  Register

Indexing

Best Paper Awards

European Journal of Biomedical and Pharmaceutical Sciences (EJBPS) will give best paper award in every issue in the form of money along with certificate to promote research activity of scholar.

Best Article of current issue :

Dr. Dhrubo Jyoti Sen

Download Article : Click here

News & Updation

  • EJBPS: JUNE ISSUE PUBLISHED

    JUNE 2023 Issue has been successfully launched on 1 JUNE 2023.

  • EJBPS New Impact Factor

    Its our Pleasure to Inform you that EJBPS Impact Factor has been increased from 5.467 to 6.044, due to high quality Publication at International Level.

  • Index Copernicus Value

    EJBPS Received Index Copernicus Value 77.3, due to High Quality Publication in EJBPS at International Level

  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.

    .

  • Article Invited for Publication

    Dear Researcher, Article Invited for Publication  in EJBPS coming Issue.

     

UG/PG/Ph.D Research Publication

Research Scholar of UG/PG/Ph.D can Submit their Research Article/Review Article/Case Study/Short Communication for Publication in EJBPS

Downloads

Copyright From

Covering Letter

                        Author Instruction 
 

PLAGERLUM REPORT